| 235 |
decreased |
sodium:iodide symporter activity
(GO:0008507)
|
sodium/iodide cotransporter
(PR:000015171)
|
424: Inhibition, Na+/I- symporter (NIS)
|
| 234 |
increased |
Nephropathy
(HP:0000112)
|
|
422: Increased, nephropathy
|
| 233 |
increased |
hemorrhage
(MP:0001914)
|
|
2 Events
|
| 232 |
functional change |
|
glomerular basement membrane
(UBERON:0005777)
|
421: Increased, glomerular rupture and renal hemorrhaging
|
| 231 |
abnormal |
sex ratio
(MESH:D012744)
|
|
417: skewed, sex ratio
|
| 230 |
increased |
hormone biosynthetic process
(GO:0042446)
|
Luteinizing hormone
(CHEBI:81568)
|
414: Increase, Luteinizing hormone (LH)
|
| 229 |
increased |
ionotropic glutamate receptor activity
(GO:0004970)
|
ionotropic glutamate receptor complex
(GO:0008328)
|
875: Binding of agonist, Ionotropic glutamate receptors
|
| 228 |
functional change |
DNA repair
(GO:0006281)
|
Nuclear deoxyribonucleic acid
(FMA:67194)
|
493: Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts
|
| 227 |
increased |
hepatocyte proliferation
(GO:0072574)
|
hepatocyte
(CL:0000182)
|
2 Events
|
| 226 |
increased |
mutation
(MESH:D009154)
|
cellular tumor antigen p53
(PR:000003035)
|
376: Increased, Induced Mutations in Critical Genes
|
| 225 |
increased |
metabolic process
(GO:0008152)
|
|
409: Metabolism of AFB1, Production of Reactive Electrophiles
|
| 224 |
abnormal |
DNA alkylation
(GO:0006305)
|
Nuclear deoxyribonucleic acid
(FMA:67194)
|
373: Formation, Pro-mutagenic DNA Adducts
|
| 223 |
morphological change |
anatomical structure morphogenesis
(GO:0009653)
|
|
1001: Increased, Developmental Defects
|
| 222 |
abnormal |
|
capillary plexus
(UBERON:0035753)
|
298: Insufficiency, Vascular
|
| 221 |
decreased |
blood circulation
(GO:0008015)
|
blood
(UBERON:0000178)
|
298: Insufficiency, Vascular
|
| 220 |
abnormal |
endothelium development
(GO:0003158)
|
|
110: Impairment, Endothelial network
|
| 219 |
decreased |
angiogenesis
(GO:0001525)
|
|
28: Reduction, Angiogenesis
|
| 218 |
decreased |
vascular endothelial growth factor receptor 2 binding
(GO:0043184)
|
vascular endothelial growth factor receptor 1
(PR:000007563)
|
305: Inhibition, VegfR2
|
| 217 |
decreased |
vascular endothelial growth factor receptor 2 binding
(GO:0043184)
|
vascular endothelial growth factor receptor 2
(PR:000002112)
|
305: Inhibition, VegfR2
|
| 216 |
decreased |
cognition
(GO:0050890)
|
|
402: Cognitive function, decreased
|
| 215 |
decreased |
learning or memory
(GO:0007611)
|
|
402: Cognitive function, decreased
|
| 214 |
decreased |
thyroid hormone generation
(GO:0006590)
|
thyroid hormone
(CHEBI:60311)
|
277: Thyroid hormone synthesis, Decreased
|
| 213 |
decreased |
iodide peroxidase activity
(GO:0004447)
|
thyroid peroxidase
(PR:000016584)
|
279: Thyroperoxidase, Inhibition
|
| 212 |
increased |
|
Bile Duct Neoplasms
(MESH:D001650)
|
856: Formation, Hepatocellular and Bile duct tumors
|
| 211 |
increased |
hyperplasia
(MESH:D006965)
|
intrahepatic bile duct epithelial cell
(CL:0002538)
|
854: Alterations, Cellular proliferation / hyperplasia
|